Natural solutions are already better for the environment. But there’s one company taking it a step further: Their natural pesticides outperform chemical alternatives. That’s already led to 200% revenue growth, thanks to e-commerce partnerships with companies like Walmart, Amazon, and Kroger.

See how you can become a shareholder while they’re still private.

STRO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $60,925.00

Sutro Biopharma Insider Trading History Chart

Sutro Biopharma Share Price & Price History

^$4.61

▲ +0.19 (4.30%)

As of 09/11/2024 01:00 AM ET

Days: 30 | 90 | 365

War on Elon Escalates…

From Porter & Company | Ad

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Sutro Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/29/2024	Nicki Vasquez	Insider	Sell	12,185	$5.00	$60,925.00	12,803
8/28/2023	Brunilda Shtylla	Insider	Sell	15,428	$4.71	$72,665.88
8/25/2023	Brunilda Shtylla	Insider	Sell	11,613	$4.59	$53,303.67	12,928
3/14/2022	William J Newell	CEO	Buy	10,000	$7.75	$77,500.00
9/28/2021	Nicki Vasquez	Insider	Sell	3,906	$18.62	$72,729.72

War on Elon Escalates…

From Porter & Company | Ad

One company holds a near-total monopoly on it.

SEC Filings (Institutional Ownership Changes) for Sutro Biopharma (NASDAQ:STRO)

96.99% of Sutro Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sutro Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/19/2024	Point72 Asset Management L.P.	4,447,634	$13.03M	0.0%	+1,606.1%	5.427%
8/16/2024	Algert Global LLC	12,829	$38K	0.0%	-46.0%	0.016%
8/15/2024	Susquehanna Fundamental Investments LLC	225,367	$0.66M	0.0%	+78.2%	0.276%
8/15/2024	The Manufacturers Life Insurance Company	32,943	$97K	0.0%	+27.4%	0.040%
8/15/2024	Millennium Management LLC	4,361,893	$12.78M	0.0%	-7.9%	5.333%
8/15/2024	AQR Capital Management LLC	283,516	$0.83M	0.0%	+691.5%	0.347%
8/14/2024	Cubist Systematic Strategies LLC	16,463	$48K	0.0%	-91.5%	0.020%
8/14/2024	ProShare Advisors LLC	16,316	$48K	0.0%	+49.1%	0.020%
8/12/2024	XTX Topco Ltd	32,356	$95K	0.0%	-63.6%	0.040%
8/12/2024	Hsbc Holdings PLC	60,858	$0.17M	0.0%	+9.7%	0.074%
8/9/2024	Renaissance Technologies LLC	719,497	$2.11M	0.0%	+48.1%	0.880%
8/9/2024	Dimensional Fund Advisors LP	1,085,281	$3.18M	0.0%	-17.1%	1.327%
8/8/2024	American Century Companies Inc.	66,812	$0.20M	0.0%	-9.2%	0.082%
8/6/2024	Acadian Asset Management LLC	1,574,958	$4.61M	0.0%	+30.8%	1.926%
8/1/2024	Rhumbline Advisers	116,099	$0.34M	0.0%	+23.3%	0.142%
7/29/2024	Principal Financial Group Inc.	10,853	$32K	0.0%	-41.8%	0.013%
7/29/2024	Panagora Asset Management Inc.	907,503	$2.66M	0.0%	+15.6%	1.109%
7/26/2024	Bank of New York Mellon Corp	272,719	$0.80M	0.0%	+47.7%	0.333%
7/12/2024	SG Americas Securities LLC	14,772	$43K	0.0%	-30.3%	0.018%
5/20/2024	Virtu Financial LLC	63,157	$0.36M	0.0%	+276.7%	0.077%
5/16/2024	California State Teachers Retirement System	6,124	$35K	0.0%	-38.1%	0.010%
5/16/2024	Jacobs Levy Equity Management Inc.	1,069,522	$6.04M	0.0%	+214.3%	1.713%
5/15/2024	Public Employees Retirement System of Ohio	96,657	$0.55M	0.0%	+56.5%	0.155%
5/15/2024	Price T Rowe Associates Inc. MD	18,027	$0.10M	0.0%	+24.8%	0.029%
5/15/2024	Lazard Asset Management LLC	16,386	$92K	0.0%	N/A	0.026%
5/14/2024	EntryPoint Capital LLC	69,678	$0.39M	0.4%	N/A	0.112%
5/10/2024	Acadian Asset Management LLC	1,204,253	$6.80M	0.0%	+30.5%	1.929%
5/10/2024	Vanguard Group Inc.	3,022,790	$17.08M	0.0%	+4.6%	4.841%
5/9/2024	State Board of Administration of Florida Retirement System	12,293	$69K	0.0%	-28.8%	0.020%
5/8/2024	Russell Investments Group Ltd.	111,955	$0.63M	0.0%	+192.9%	0.179%
5/7/2024	Susquehanna Fundamental Investments LLC	126,459	$0.71M	0.0%	N/A	0.203%
5/7/2024	SG Americas Securities LLC	21,193	$0.12M	0.0%	-48.0%	0.034%
5/2/2024	Chase Investment Counsel Corp	57,700	$0.33M	0.1%	N/A	0.092%
5/1/2024	BNP Paribas Financial Markets	98,227	$0.56M	0.0%	+500.1%	0.157%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	44,019	$0.25M	0.0%	N/A	0.070%
5/1/2024	Baillie Gifford & Co.	1,846,906	$10.44M	0.0%	-1.1%	2.958%
2/15/2024	Opaleye Management Inc.	301,491	$1.29M	0.3%	N/A	0.495%
2/15/2024	Parkman Healthcare Partners LLC	1,202,431	$5.16M	0.7%	+1.7%	1.973%
2/14/2024	Kynam Capital Management LP	2,001,727	$8.59M	1.0%	+28.9%	3.284%
2/14/2024	Sectoral Asset Management Inc.	623,684	$2.68M	1.2%	+44.3%	1.023%
2/13/2024	Aristides Capital LLC	50,476	$0.22M	0.1%	N/A	0.083%
2/13/2024	Tower Research Capital LLC TRC	9,396	$40K	0.0%	-37.9%	0.015%
2/9/2024	Franklin Resources Inc.	2,762,636	$11.85M	0.0%	-2.5%	4.533%
2/9/2024	Dynamic Technology Lab Private Ltd	13,899	$60K	0.0%	N/A	0.023%
2/8/2024	Panagora Asset Management Inc.	451,692	$1.94M	0.0%	+22.4%	0.741%
2/5/2024	Russell Investments Group Ltd.	38,224	$0.16M	0.0%	-64.8%	0.063%
1/31/2024	abrdn plc	69,389	$0.30M	0.0%	N/A	0.114%
1/30/2024	Vontobel Holding Ltd.	641,684	$2.75M	0.0%	+42.5%	1.053%
1/25/2024	Nisa Investment Advisors LLC	8,820	$38K	0.0%	+14,125.8%	0.014%
1/12/2024	SG Americas Securities LLC	40,779	$0.18M	0.0%	+25.6%	0.067%
1/5/2024	Exchange Traded Concepts LLC	35,856	$0.15M	0.0%	+34.0%	0.059%
11/15/2023	Sectoral Asset Management Inc.	432,339	$1.50M	0.3%	+7.9%	0.715%
11/15/2023	Kynam Capital Management LP	1,552,675	$5.39M	0.9%	+3.5%	2.566%
11/15/2023	Adage Capital Partners GP L.L.C.	3,105,132	$10.78M	0.0%	+1,275.7%	5.132%
11/14/2023	Pentwater Capital Management LP	430,000	$1.49M	0.0%	+7.5%	0.711%
11/14/2023	Rubric Capital Management LP	3,344,810	$11.61M	0.4%	-17.4%	5.529%
11/13/2023	Acadian Asset Management LLC	773,867	$2.68M	0.0%	+18.2%	1.279%
11/7/2023	Barclays PLC	62,579	$0.22M	0.0%	+40.7%	0.103%
11/6/2023	Los Angeles Capital Management LLC	68,324	$0.24M	0.0%	+20.9%	0.113%
10/31/2023	Panagora Asset Management Inc.	369,148	$1.28M	0.0%	+8.3%	0.610%
10/24/2023	Bank of New York Mellon Corp	261,451	$0.91M	0.0%	+3.4%	0.432%
10/13/2023	SG Americas Securities LLC	32,465	$0.11M	0.0%	N/A	0.054%
10/11/2023	Vontobel Holding Ltd.	450,339	$1.56M	0.0%	+8.3%	0.744%
8/15/2023	Suvretta Capital Management LLC	5,883,693	$27.36M	1.5%	+3.4%	9.720%
8/15/2023	Kynam Capital Management LP	1,500,000	$6.98M	1.0%	+66.3%	2.478%
8/11/2023	Panagora Asset Management Inc.	340,988	$1.59M	0.0%	-21.1%	0.567%
8/11/2023	Sectoral Asset Management Inc.	400,646	$1.86M	0.3%	N/A	0.666%
8/11/2023	Rubric Capital Management LP	4,048,744	$18.83M	0.8%	-7.1%	6.727%
8/11/2023	Franklin Resources Inc.	2,867,535	$13.33M	0.0%	+1.0%	4.764%
8/11/2023	Trexquant Investment LP	102,548	$0.48M	0.0%	-43.9%	0.170%
8/11/2023	Tejara Capital Ltd	88,682	$0.41M	0.2%	+99.4%	0.147%
8/8/2023	Fisher Asset Management LLC	196,517	$0.91M	0.0%	N/A	0.326%
8/8/2023	Candriam S.C.A.	1,628,234	$7.57M	0.1%	-12.5%	2.705%
8/7/2023	Principal Financial Group Inc.	18,982	$88K	0.0%	+23.7%	0.032%
8/7/2023	Acadian Asset Management LLC	654,468	$3.04M	0.0%	-4.8%	1.087%
8/4/2023	American International Group Inc.	28,950	$0.14M	0.0%	+11.3%	0.048%
8/3/2023	Los Angeles Capital Management LLC	56,524	$0.26M	0.0%	+23.3%	0.094%
7/24/2023	Allspring Global Investments Holdings LLC	18,227	$85K	0.0%	-23.8%	0.030%
7/24/2023	Vontobel Holding Ltd.	415,646	$1.93M	0.0%	+3,097.3%	0.691%
7/20/2023	Exchange Traded Concepts LLC	25,611	$0.12M	0.0%	N/A	0.043%
7/18/2023	Diversified Trust Co	11,189	$52K	0.0%	N/A	0.019%
7/18/2023	Allspring Global Investments Holdings LLC	18,227	$85K	0.0%	-23.8%	0.030%
6/1/2023	Prelude Capital Management LLC	30,788	$0.14M	0.0%	+59.9%	0.051%
5/15/2023	Suvretta Capital Management LLC	5,689,086	$26.28M	1.1%	+2.2%	9.452%
5/15/2023	Rubric Capital Management LP	4,360,487	$20.15M	0.5%	+35.8%	7.244%
5/12/2023	Panagora Asset Management Inc.	431,982	$2M	0.0%	+38.0%	0.718%
5/12/2023	Tejara Capital Ltd	44,483	$0.21M	0.1%	N/A	0.074%
5/11/2023	Acadian Asset Management LLC	687,235	$3.17M	0.0%	+22.3%	1.142%
5/11/2023	E Fund Management Co. Ltd.	12,245	$57K	0.0%	N/A	0.020%
5/10/2023	Simplify Asset Management Inc.	120,000	$0.55M	0.1%	N/A	0.199%
5/10/2023	Tekla Capital Management LLC	98,354	$0.45M	0.0%	-33.3%	0.163%
5/9/2023	Russell Investments Group Ltd.	139,829	$0.65M	0.0%	+28.3%	0.232%
5/4/2023	Barclays PLC	121,144	$0.56M	0.0%	+47.9%	0.201%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	53,608	$0.25M	0.0%	+176.7%	0.089%
5/4/2023	Los Angeles Capital Management LLC	45,854	$0.21M	0.0%	-27.4%	0.076%
4/13/2023	Allspring Global Investments Holdings LLC	23,905	$0.11M	0.0%	-22.1%	0.040%
4/12/2023	Vontobel Holding Ltd.	13,000	$60K	0.0%	+30.0%	0.022%
3/23/2023	MetLife Investment Management LLC	28,380	$0.23M	0.0%	+17.9%	0.049%
2/15/2023	Endurant Capital Management LP	281,895	$2.28M	0.9%	+5.7%	0.491%
2/14/2023	Verition Fund Management LLC	1,604,229	$12.96M	0.2%	+27.9%	2.791%

Data available starting January 2016

Sutro Biopharma, Inc. operates as a clinical-stage oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF and XpressCF+. Its product candidates include STRO-002, an ADC directed against folate receptor-alpha, which is in Phase II/III clinical trials for patients with ovarian and endometrial cancers; VAX-24 and Vax-31 pneumococcal conjugate vaccine candidates that is in Phase II/III clinical trials for the treatment of invasive pneumococcal disease; and MK-1484, a distinct cytokine derivative molecule that is in Phase I clinical study for the treatment of cancer. The company's pre-clinical product candidates include STRO-003, an ADC directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1) for the treatment of solid tumors and hematological cancers; and STRO-004, a tissue factor (TF) targeting ADC for the treatment of TF-expressing solid tumors, including cervical, lung, and breast cancer. Sutro Biopharma, Inc. has collaboration and license agreements with Merck Sharp & Dohme Corporation to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; Vaxcyte to discover and develop vaccine candidates for the treatment or prophylaxis of infectious diseases; Tasly Biopharmaceuticals Co., Ltd. to develop and commercialize STRO-002 in Greater China; EMD Serono to develop ADCs for multiple cancer targets; and Astellas Pharma Inc. to develop immunostimulatory ADC. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

Today's Range

Now: $4.61

$4.33

$4.62

50 Day Range

MA: $3.97

$2.88

$5.01

52 Week Range

Now: $4.61

$2.01

$6.13

Volume

277,099 shs

Average Volume

854,419 shs

Market Capitalization

$377.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Who are the company insiders with the largest holdings of Sutro Biopharma?: Sutro Biopharma's top insider shareholders include:
Brunilda Shtylla (Insider)
Nicki Vasquez (Insider)
Learn More about top insider investors at Sutro Biopharma.
Who are the major institutional investors of Sutro Biopharma?: Sutro Biopharma's top institutional shareholders include:
Point72 Asset Management L.P. — 5.43%
Millennium Management LLC — 5.33%
Acadian Asset Management LLC — 1.93%
Dimensional Fund Advisors LP — 1.33%
Panagora Asset Management Inc. — 1.11%
Renaissance Technologies LLC — 0.88%
Learn More about top institutional investors of Sutro Biopharma stock.
Which institutional investors are selling Sutro Biopharma stock?: During the previous quarter, STRO stock was sold by these institutional investors:
Millennium Management LLC
Dimensional Fund Advisors LP
Cubist Systematic Strategies LLC
XTX Topco Ltd
Algert Global LLC
Principal Financial Group Inc.
American Century Companies Inc.
SG Americas Securities LLC
Which institutional investors are buying Sutro Biopharma stock?: Within the last quarter, STRO stock was acquired by institutional investors including:
Point72 Asset Management L.P.
Acadian Asset Management LLC
AQR Capital Management LLC
Renaissance Technologies LLC
Panagora Asset Management Inc.
Susquehanna Fundamental Investments LLC
Bank of New York Mellon Corp
Rhumbline Advisers

Natural is heading to the Nasdaq

From MedX | Ad